Sutro Biopharma (STRO) Other financing activities (2017 - 2025)
Sutro Biopharma (STRO) posted Other financing activities of -$1000.0 for Q4 2025, up 99.59% sequentially from -$245000.0 in Q3 2025, and up 100.0% YoY from -$500.0 in Q4 2024.
Sutro Biopharma (STRO) Other financing activities (2017 - 2025) Analysis & Trends
Sutro Biopharma has reported Other financing activities for 9 years, with the latest figure at -$1000.0 in Q4 2025.
- Quarterly Other financing activities rose 100.0% year-over-year to -$1000.0 in Q4 2025, while the trailing twelve-month figure through Sep 2025 was -$71.3 million (down 10.7% YoY) and the FY2024 annual result came in at $271000.0, down 13.69% from the prior year.
- Other financing activities rose to -$1000.0 in Q4 2025 per STRO's latest filing, from -$245000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $135.9 million in Q3 2023 and troughed at -$135.9 million in Q4 2023.
- A 5-year average of $196352.9 and a median of $246000.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2024: Other financing activities sank 5746.81% in 2022, then surged 9220.05% in 2024.
- Over 5 years, Other financing activities stood at $720000.0 in 2021, then tumbled by 5746.81% to -$40.7 million in 2022, then sank by 234.25% to -$135.9 million in 2023, then soared by 47.57% to -$71.3 million in 2024, then soared by 100.0% to -$1000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered -$1000.0, -$245000.0, and $246000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -245,000.00 |
| Sep 30, 2025 | -245,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Mar 31, 2025 | 246,000.00 |
| Dec 31, 2024 | -71.26 Mn |
| Dec 31, 2024 | -71.26 Mn |
| Jun 30, 2024 | 71.41 Mn |
| Jun 30, 2024 | 71.41 Mn |
| Mar 31, 2024 | 117,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | -135.89 Mn |
| Dec 31, 2023 | -135.89 Mn |
| Sep 30, 2023 | 135.89 Mn |
| Sep 30, 2023 | 135.89 Mn |
| Jun 30, 2023 | -783,000.00 |
| Jun 30, 2023 | -783,000.00 |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |